Joaquin Penataro-Saez

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Suspected menopause nutraceutical-induced eosinophilic ascites: a rare clinical presentation.

Suspected menopause nutraceutical-induced eosinophilic ascites: a rare clinical presentation.

Journal: BMJ case reports

Published: September 01, 2026

Incidence of drug-induced liver injury in the urban primary care setting.

Incidence of drug-induced liver injury in the urban primary care setting.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: January 13, 2026

Incidence of Drug-Induced Liver Injury in the Urban Primary Care Setting.

Incidence of Drug-Induced Liver Injury in the Urban Primary Care Setting.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: January 13, 2026

Varnimcabtagene autoleucel (ARI-0001) in relapsed or refractory mantle cell lymphoma.

Varnimcabtagene autoleucel (ARI-0001) in relapsed or refractory mantle cell lymphoma.

Journal: HemaSphere

Published: December 28, 2025

Varnimcabtagene autoleucel for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia in Spain (CART19-BE-02): a multicentre, single-arm, phase 2 trial.

Varnimcabtagene autoleucel for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia in Spain (CART19-BE-02): a multicentre, single-arm, phase 2 trial.

Journal: The Lancet. Haematology

Published: October 06, 2025

Tecovirimat hepatotoxicity in a man with Mpox infection.

Tecovirimat hepatotoxicity in a man with Mpox infection.

Journal: Enfermedades infecciosas y microbiologia clinica (English ed.)

Published: May 14, 2025

Efficacy and safety of the academic anti-CD19 chimeric antigen receptor T-cell product varnimcabtagene autoleucel for the treatment of relapsed/refractory follicular lymphoma.

Efficacy and safety of the academic anti-CD19 chimeric antigen receptor T-cell product varnimcabtagene autoleucel for the treatment of relapsed/refractory follicular lymphoma.

Journal: HemaSphere

Published: February 25, 2025

Association between Reactogenicity and Immunogenicity in a Vaccinated Cohort with Two mRNA SARS-CoV-2 Vaccines at a High-Complexity Reference Hospital: A Post Hoc Analysis on Immunology Aspects of a Prospective Cohort Study.

Association between Reactogenicity and Immunogenicity in a Vaccinated Cohort with Two mRNA SARS-CoV-2 Vaccines at a High-Complexity Reference Hospital: A Post Hoc Analysis on Immunology Aspects of a Prospective Cohort Study.

Journal: Vaccines

Published: May 07, 2024

Real-world study: Impact of multidisciplinary management of apalutamide-associated adverse events in prostate cancer.

Real-world study: Impact of multidisciplinary management of apalutamide-associated adverse events in prostate cancer.

Journal: The Prostate

Published: March 05, 2024

Activities of clinical pharmacologists across Europe: A survey by the European association of clinical pharmacology and therapeutics.

Activities of clinical pharmacologists across Europe: A survey by the European association of clinical pharmacology and therapeutics.

Journal: European journal of clinical pharmacology

Published: December 23, 2023

Anticancer drugs are the first cause of drug-induced liver injury in a reference hospital.

Anticancer drugs are the first cause of drug-induced liver injury in a reference hospital.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: December 06, 2023

Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma.

Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: December 05, 2023

Showing 1-12 of 23

Last Updated: 09/26/2026